From Evidence to Theory
Neo-Liberal Corporate Bias as a Framework for Understanding UK Pharmaceuticals Regulation – Response to Alison Edgley
Bibliographic Data
| ID | 12730237 |
|---|---|
| Authors | John Abraham (0000-0003-3643-0128, University of Sussex, corresponding author), Julian Abraham (0000-0003-0643-0274) |
| Year | 2007 |
| Volume | 5 |
| Issue | 2 |
| Pages | 161-175 |
| Publication date | 2007-04-24 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Social Theory & Health (JOURNAL) |
| Journal identifiers | ISSN: 1477-8211 • E-ISSN: 1477-822X |
| Publisher | Palgrave Macmillan (PUBLISHER • GB) |
| DOI | 10.1057/palgrave.sth.8700097 |
| OpenAlex | W1984189867 |
| Language | EN |
| Citations received | 11 |
| References cited | 8 |
Economics · Law and economics · Political science · Positive economics · Public economics · State (computer science · Healthcare cost, quality, practices · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare
Theory
Neoliberal pharmaceutical science and the Chicago School of Economics
Drug Evaluation and the Permissive Principle
Sociology of pharmaceuticals development and regulation
Divergent spender
Regulating drug information in Europe
Public-private partnerships and the politics of alcohol policy in England
Prohibiting or ‘managing’ conflict of interest? A review of policies and procedures in three European drug regulation agencies
Les laboratoires pharmaceutiques et la construction d'une régulation européenne des médicaments
Governing drug reimbursement policy in Poland
The Neoliberal Regulatory State, Industry Interests, and the Ideological Penetration of Scientific Knowledge
| Citations per year | 0.58 |
|---|---|
| Citation span | 2007 - 2021 (15) |
| Highly cited | No |